转自:北京日报客户端在北京市药品检验研究院生化生检室,检验人员正在对罕见病药品有效成分进行测定。在北京大学肿瘤医院,药房中各类药物流转不停,京企自主研发的抗癌新药泽布替尼、奥布替尼等多款已获批上市的创新药就在其中,为患者带来希望。深化罕见病药品保障先行区和临床急需进口药械审批绿色通道建设、优化创新药临床试验审评审批试点、开展生物制品分段生产试点……近年来,本市在医药健康领域深化全产业链开放、全环节...
Source Link转自:北京日报客户端在北京市药品检验研究院生化生检室,检验人员正在对罕见病药品有效成分进行测定。在北京大学肿瘤医院,药房中各类药物流转不停,京企自主研发的抗癌新药泽布替尼、奥布替尼等多款已获批上市的创新药就在其中,为患者带来希望。深化罕见病药品保障先行区和临床急需进口药械审批绿色通道建设、优化创新药临床试验审评审批试点、开展生物制品分段生产试点……近年来,本市在医药健康领域深化全产业链开放、全环节...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.